McHutchison JG - Search Results

1

The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA.

Patel K, Albrecht J, Owens E, Dev A, Heaton S, Pianko S, Pockros PJ, Conrad A, Blatt LM, McHutchison JG. Patel K, et al. Among authors: mchutchison jg. Antivir Ther. 2005;10(4):535-41. Antivir Ther. 2005. PMID: 16038479

2

Future therapy of hepatitis C.

McHutchison JG, Patel K. McHutchison JG, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S245-52. doi: 10.1053/jhep.2002.36795. Hepatology. 2002. PMID: 12407600 Review.

3

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros PJ, Blatt LM, Conrad A, McHutchison JG. Patel K, et al. Among authors: mchutchison jg. J Gastroenterol Hepatol. 2003 Mar;18(3):253-7. doi: 10.1046/j.1440-1746.2003.02930.x. J Gastroenterol Hepatol. 2003. PMID: 12603524

4

Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patients.

Patel K, McHutchison JG. Patel K, et al. Among authors: mchutchison jg. Postgrad Med. 2003 Jul;114(1):48-52, 57-9, 62. doi: 10.3810/pgm.2003.07.1452. Postgrad Med. 2003. PMID: 12875055 Review.

5

New therapies for chronic hepatitis C virus infection.

Dev A, Patel K, McHutchison JG. Dev A, et al. Among authors: mchutchison jg. Curr Gastroenterol Rep. 2004 Feb;6(1):77-86. doi: 10.1007/s11894-004-0030-5. Curr Gastroenterol Rep. 2004. PMID: 14720458 Review.

6

Future trends in managing hepatitis C.

McHutchison JG, Dev AT. McHutchison JG, et al. Gastroenterol Clin North Am. 2004 Mar;33(1 Suppl):S51-61. doi: 10.1016/j.gtc.2003.12.001. Gastroenterol Clin North Am. 2004. PMID: 15081103

7

Hepatitis C and steatosis.

Dev A, Patel K, McHutchison JG. Dev A, et al. Among authors: mchutchison jg. Clin Liver Dis. 2004 Nov;8(4):881-92, ix. doi: 10.1016/j.cld.2004.06.007. Clin Liver Dis. 2004. PMID: 15464660 Review.

8

Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration.

Patel K, McHutchison JG. Patel K, et al. Among authors: mchutchison jg. Cleve Clin J Med. 2004 May;71 Suppl 3:S8-12. doi: 10.3949/ccjm.71.suppl_3.s8. Cleve Clin J Med. 2004. PMID: 15468611 Free article. Review.

9

A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.

McHutchison JG, Patel K, Pockros P, Nyberg L, Pianko S, Yu RZ, Dorr FA, Kwoh TJ. McHutchison JG, et al. J Hepatol. 2006 Jan;44(1):88-96. doi: 10.1016/j.jhep.2005.09.009. Epub 2005 Oct 25. J Hepatol. 2006. PMID: 16274834 Clinical Trial.

10

Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients.

Patel K, Lim SG, Cheng CW, Lawitz E, Tillmann HL, Chopra N, Altmeyer R, Randle JC, McHutchison JG. Patel K, et al. Among authors: mchutchison jg. Antivir Ther. 2011;16(8):1341-6. doi: 10.3851/IMP1898. Antivir Ther. 2011. PMID: 22155916 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters